🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study is to evaluate the safety of melphalan and autologou...
Status
Terminated
Location
Emory University Winship Cancer Institute
Start Date
2005-05
Trial ID
NCT00793650
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of induction the...
Status
Completed
Location
Duke University Medical Center
Start Date
2008-08
Trial ID
NCT00691704
Treatments Being Tested
RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-01-16
Trial ID
NCT00792142
The purpose of the study is to determine the best treatment approach based ...
Status
Not Yet Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2026-06-08
Trial ID
NCT07624513
The purpose of the study is to identify specific genes that are up- or down...
Status
Unknown
Location
Department of Haematology, Aalborg University Hospital
Start Date
2014-01
Trial ID
NCT02109861
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of Bortezomib wh...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2009-06-18
Trial ID
NCT00948922
Treatments Being Tested
This protocol is planned as a multicentric, national, open-label trial desi...
Status
Completed
Location
Hospital Clínic
Start Date
2004-04
Trial ID
NCT00388635
Treatments Being Tested
Multiple myeloma (MM) is a neoplastic disease deriving from an abnormal pro...
Status
Active Not Recruiting
Location
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Start Date
2019-01-03
Trial ID
NCT03829371
Treatments Being Tested
The hypothesis for this study is that the regimen consisting of fludarabine...
Status
Completed
Location
John Theurer Cancer Center at Hackensack University Medical Center
Start Date
2010-06-09
Trial ID
NCT01453101
Treatments Being Tested
The primary reason for this study is to further assess safety and efficacy ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00799539
Treatments Being Tested